Article info

Download PDFPDF
Original article
Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Authors

  1. Correspondence to Casper Steenholdt, Department of Gastroenterology, Herlev Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark; steenholdt{at}brygge.dk
View Full Text

Citation

Steenholdt C, Brynskov J, Thomsen, et al
Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Publication history

  • Received May 14, 2013
  • Revised July 3, 2013
  • Accepted July 4, 2013
  • First published July 22, 2013.
Online issue publication 
October 26, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.